0% found this document useful (0 votes)
15 views39 pages

Adverse Drug Reactions Final

Adverse drug reactions (ADRs) are unintended and noxious responses to medications that occur at normal therapeutic doses, with significant epidemiological implications including 30% of medical inpatients experiencing ADRs. They can be classified into different types based on their relationship to dosage and timing, with varying severities and impacts on patient health. Strategies to mitigate ADRs include rational prescribing, patient education, and monitoring for early symptoms.

Uploaded by

9x52bqbjp7
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
15 views39 pages

Adverse Drug Reactions Final

Adverse drug reactions (ADRs) are unintended and noxious responses to medications that occur at normal therapeutic doses, with significant epidemiological implications including 30% of medical inpatients experiencing ADRs. They can be classified into different types based on their relationship to dosage and timing, with varying severities and impacts on patient health. Strategies to mitigate ADRs include rational prescribing, patient education, and monitoring for early symptoms.

Uploaded by

9x52bqbjp7
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
You are on page 1/ 39

ADVERSE DRUG

REACTIONS
Definition:

Any response that is


noxious and
unintended, that occurs
at the doses used for
diagnosis, prevention
and treatment of
diseases.
The World Health
Organization defines it
as:
An adverse drug reaction (ADR)
is ‘a response to a medicine
which is noxious, undesirable
and unintended, and which
occurs at doses normally used
in human for diagnosis,
prophylaxis and treatment ’.
EPIDEMIOLOGY :
 30% of medical inpatients
develop an ADR
 3% of all hospital admissions are

due to ADRs
 Risk of an allergic reaction is

approximately 1-3%
Types:

1. Side effects

2. Untoward effects

3. Toxic effects
(1) SIDE EFFECTS:

These are pharmacological effects of


drugs produced at therapeutic doses,
that depending upon condition may be
desirable and undesirable

Eg: Atropine produces dryness of


mouth, it is side effect when
drug is given for sinus bradycardia,
but it is desired when the drug is
given as pre- anesthetic medication
(2) UNTOWARD EFFECTS:

 These are the undesired effects


produced at the therapeutic doses

 They necessitate the cessation of


therapy

 Eg: Hypokalemia produced by loop


diuretics
(3) TOXIC EFFECTS:

 These are produced


when drug is rapidly
administered or when
drug is given in large
doses

 Eg: Respiratory
depression produced by
morphine
Impact of ADRs :

 Increased risk of death

 Prolongation of hospital stay


FREQUENCY.
The World Health Organization
recommends

 very common (>1/10 patients)


 common (>1/100)

 uncommon (>1/1000)
 rare (>1/10,000)
 very rare (<1/100,000)
CLASSIFICATION ;
Rawlin and Thompson
(1991)
Type A:
 Dose-related; pharmacologically
predictable, high morbidity, low mortality.
This type was the most common with the
most common offending drugs being
warfarin, insulin, and digoxin.
 Toxicity of overdose (e.g. hepatic failure with
high dose Paracetamol),
 Side effects (e.g. sedation with antihistamines) ,
 Secondary effects (e.g. development of diarrhea
with antibiotic therapy due to altered
gastrointestinal bacterial flora),
 Drug interaction (e.g. Theophylline toxicity in
the presence of erythromycin therapy)
Type B:
 Non-dose related; bizarre
and unpredictable, low
morbidity, high mortality.

 Intolerance (e.g. tinnitus


with use of Aspirin).

 Immune related such as


hypersensitivity reactions
(e.g. Anaphylaxis with
penicillin administration ).
 Pseudoallergic /non-immunologic-
radio contrast dye
 Non-immune reactions such as
porphyria, neuroleptic malignant
syndrome, or malignant
hyperthermia.
 Idiosyncratic reaction(e.g.
development of anemia with the
use of anti-oxidant drugs in The
presence of glucose-6 phosphate
dehydrogenase deficiency).
Type C:
 Dose-related and time-related.
This is related to duration and
dosage of exposure. These
reactions are associated with
long-term drug therapy.
 An example is hypothalamic-
pituitary-adrenal suppression
from glucocorticoid therapy.
 Benzodiazepine dependence &
Analgesic nephropathy.
 They are well known and can be
anticipated.
Type D:
 These reactions refer to
carcinogenic and
teratogenic effects.
 These reactions are

delayed in onset and are


very rare since extensive
mutagenicity and
carcinogenicity studies are
done before drug is
licensed. ..
Type E:
 Withdrawal; end of dose
reaction. An example is narcotic
or beta-blocker withdrawal.
Type F:
 Unexpected failure of therapy.
This may be caused by drug
interactions. An example is
failure of oral contraceptives
due to induction of enzymes by
a second drug.
Severity of ADR:
 Minor: no need of therapy,
antidote, or hospitalization
 Moderate: requires drug change ,

specific treatment, hospitalization


 Severe: Potentially life

threatening; permanent damage,


and prolonged hospitalization.
 Lethal: Directly or indirectly leads

to death
Strategies to Avoid ADR :

 Avoid poly pharmacy


 Rational prescribing
 Prescribe the drugs of known ADR only when
there is no choice left
 Obtain history of the patient

 Educate the patient about the early symptoms of


ADR
 A person susceptible to certain reaction should be
provided with cards Strategies to Avoid ADR
ADR detection methods :
 Premarketing clinical trials
 Post approval spontaneous case reports

 Aggregate population-based data

sources
 Computerized data collections

 Post marketing studies

 Case reports ADR detection methods


IMPORTANT SYSTEMIC
SIDE EFFECTS:
1. Drug intolerance
2. GIT disturbances
3. Hemopoietic toxicity
4. Hepatotoxicity
5. Nephrotoxicity
6. Behavioral toxicity
7. Electrolyte imbalance
8. Endocrine disturbances
9. Skin toxicity
10. Carcinogenesis
11. Teratogenecity
12. Drug dependence
13. Unmasking of diseases
14. Iatrogenic effect
1) DRUG INTOLERENCE:
It is the inability to tolerate drugs.

1. Quantitative: "Hyper-reactors“. Eg:


GIT bleeding and vomiting with single
dose of salicylates

2. Qualitative
*Idiosyncrasy
*Hypersensitivity
(B) Qualitative Intolerance:
Idiosyncrasy (Allergy):
 An exaggerated sensitivity to certain
foreign substances which are
harmless to majority of population

 It has an immunological basis


approximately 10% of all the adverse
reactions are allergic reactions

 Drugs commonly producing allergic


reactions are penicillins,
sulfonamides, quinidine, insulin and
dextran
Types of
Hypersensitivity:
Type I:
 Immediate form of allergy,
minutes or hours after taking of
drug
 The underlying immune
reaction is initiated by the
attachment of antigen to Ig E
antibodies to the surface of
mast cells and basophils.
 Erythema, urticaria, itching,
bronchoconstriction, edema.
abdominal cramps and diarrhea histami
 Anaphylaxis is the severe form ne
of Type I reaction causes
cardiopulmonary collapse
Type II:

IgG
 Responses are usually
delayed, and may take
several hours to several days
for appearance after drug
exposure
 Haemolysis, leucopenia and
thrombocytopenia
Type III:
 Immune complexes are formed between antigen and
antibody, and these complexes are deposited in small
vessels or within interstitial spaces resulting in
activation of complement cascade that attract
neutrophils

 The lysosomal enzymes liberated by neutrophils


cause local damage and promote thrombosis of
affected blood vessels
Type IV:
 Sensitized T-lymphocytes
 Reaction is usually delayed
(2) GIT DISTURBANCES:

 Many drugs produce GIT


disturbances like nausea and
vomiting eg: digitalis, reserpine and
anticancer drugs
 Constipation is produced by opiates,
verapamil and anticancer drugs
 Certain drugs produce diarrhea like
colchicine and progesterone
(3) HEMOPOIETIC TOXICITY:

 Anemia: chloramphenicol, primaquine,


methyldopa, sulfonamides
 Leukopenia: phenylbutazone,
thiouracil, chlorpromazine, imipramine
chloramphenicol
 Thrombocytopenia: quinidine,
tolbutamide, digitalis, rifampin
 Bleeding: aspirin, corticosteroids,
heparin and warfarin
(4) HEPATOTOXICITY:

 Patients with liver damage may remain


asymptomatic or hepatotoxicity is
manifested as hepatomegaly, abdominal
pain or jaundice.

 Direct hepatotoxicity may be caused by


isoniazid, tetracyclines and halothane.

 Certain drugs cause immunological


disturbances like isoniazid, rifampin,
pyrazinamide, methyldopa, indomethacin
and chlorpromazine.
(5) NEPHROTOXICITY:

 Many drugs cause nephrotoxicity


like aminoglycosides, amphotericin
B, vancomycin, bacitracin,
polymixins, sulfonamides,
hydralazine, penicillinamine,
phenacetin and acetaminophen
(6) BEHAVARIOURAL TOXICITY:
 Reserpine causes suicidal

tendencies, amphetamine causes


disorientation and confusion and
glucocorticoids cause euphoria

(7) ELECTROLYTE
DISTURBANCES:
 Diuretics produce hypokalemia, and

carbenexolone and corticosteroids


produce hypernatremia
(8) ENDOCRINE DISTURBANCES:

 Chlorpromazine cause menstrual irregularities


 Oral contraceptives cause suppression of
lactation
 Corticosteroids cause hyperglycemia

 Cimetidine and ketoconazole cause


gyanaecomastia
 Lithium carbonate cause goiter

(9) SKIN TOXICITY:

 Skin rashes (urticaria) can be produced by


penicillin, cephalosporins, amiodarone,
clofazemine, sulfonamides and tetracyclines
(10) CARCINOGENESIS:

 Certain drugs lead to carcinogenesis


 Eg: Estrogens produce breast and
endometrial cancer
Reserpine produce breast cancer
Metronidazole produces certain
tumors

(11) TERATOGENECITY:
 Some drugs produce developmental
abnormalities in fetus, when given in
pregnancy
 Eg: Phocomelia by thalidomide and cleft
(12) DRUG DEPENDENCE:
 Certain drugs when used repeatedly,
may make individual psychologically
and physically dependent on the drug i-
e discontinuation of drug may produce
withdrawal syndrome eg: morphine,
alcohol, cocaine

(13) UNMASKING OF THE DISEASE:


 Thiazide and corticosteroids unmask
the diabetes mellitus
 Isoniazid unmask the epilepsy

(14) IATROGENIC EFFECT:


 Antipsychotic drugs produce
Parkinson’s disease
 NSAIDs produce peptic ulcer

You might also like